Navigation Links
When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell
Date:9/20/2007

at cover the surface of the proteins: When two proteins react they squeeze the water molecules out of the area where they bind together. This displacement changes the density of the liquid slightly which, in turn, alters its index of refraction.

BSI has some potential cost advantages compared to current techniques. The price of the equipment required for BSI is modest and the entire system could easily be miniaturized and integrated with lab on a chip systems, says Bornhop. It is also easy to adapt for high-throughput operation: processing hundreds or thousands of different samples at the same time, he says.

Vanderbilt has applied for and received two patents on the process and has several other patents pending. The university has issued an exclusive license to develop the technology to Molecular Sensing, Inc. Bornhop is one of the founders of the start-up and serves as its chief scientist. The company plans on completing a prototype system this fall.


'/>"/>

Contact: David F. Salisbury
david.salisbury@vanderbilt.edu
615-343-6803
Vanderbilt University
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. 2100 expert software Powerful software for the analysis of RNA, DNA, proteins, and cells with the Agilent 2100 bioanalyzer
2. Continuous-Elution Electrophoresis for Purification of the Baculovirus-Expressed Coronavirus Structural Proteins, Rev A
3. Application of the Bio-Plex Cell Lysis Kit in Western Blot Analysis of Phosphoproteins, Rev A
4. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
5. Simple, Sensitive Isotyping of Mouse Monoclonal Antibodies
6. Quality control of antibodies using the 2100 bioanalyzer and the Protein 200 Plus assay
7. Mirus announces new method for making antibodies
8. Using THERMAL DESORPTION GAS CHROMATOGRAPHY for the identification of fragrance and other components in cosmetic products
9. Milwaukee takes another step in electronic patient data exchange
10. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
11. Early Stage: Step 11 - Other forms of finance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... communication, computation and more powerful ways...se quantum states as carriers of information is an...ave shown, mathematically, how to gently tease out...eping the information intact. Their work is report...s and highlighted with a Viewpoint in Physics (...
(Date:11/23/2009)...wswire-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: ...er27,2009astheex-dividenddateforits$200millionspec...ationtransactioncompletedonNovember2,2009.Thedivid...ecordontherecorddate,December1,2009.NASDAQhassetth...hareofcommonstockforpurposesoftheex-dividenddateon...
(Date:11/23/2009)...-FirstCall/--NeogenCorporation(Nasdaq: NEOG )annou...ogen,sBoardofDirectorsatthecompany,srecentannualme...rsofexperienceinthefood,agriculture,andtradeindust...lturaleconomicsatVirginiaTechUniversity.FromJanuar...ulturenegotiatorwiththerankofambassador. ,, "Si...
(Date:11/23/2009)...uneDesignC or p.(IDC)announcedtodaythatDr.BruceL.A...sasuccessfultrackrec or dinbiotechnologyexecutivem...ymoGenetics,inSeattle,WAandChiefScientificOfficera...ttp://www.newscom.com/cgi-bin/prnh/20091123/SF1522...iveOfficercommented,"IamdelightedtowelcomeDr.Bruce...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Richard T. Crowder Joins Neogen's Board of Directors 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2
...ocus on Late-Stage and Marketed ...nd OXFORD, England, May 1 ,EUSA Pharma Inc (,EUSA,...y,focused on oncology, pain control and critical c...clonal antibody research business to the French,co...rently, EUSA has,divested its recombinant L-aspara...
...sdaq:,VICL) today announced that the company will ...ch 31, 2008, before the opening of trading on,Thur...cast to discuss the,financial results and provide ... May 8. The call is open on a listen-only basis to...details on independent and partnered,development p...
...:,FVRL), a biopharmaceutical company developing pa...atment of cancer, announced today that it will,hos...Eastern Time on,Thursday, May 8, 2008 to discuss t... A press release will be issued after the U.S. sto...wscom.com/cgi-bin/prnh/20080404/LAF521LOGO ), A l...
Other Biology Technology:EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product 2EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product 3Vical Announces News Release and Conference Call Schedule for First Quarter 2008 Financial Results 2Favrille to Host Conference Call and Live Webcast to Discuss First Quarter 2008 Financial Results on May 8, 2008 2
(Date:11/24/2009)...ON ROUGE Antarctica has long held secrets of the ...l recently, there has been very little information... miles of ice for millions of years. Now, a team o...U have been funded to the tune of $10 million dol...o get to the bottom of things literally. These sc...
(Date:11/23/2009)...ngton, D.C. The community-associated strain of th...a resistant to most common antibioticsposes a far ... making its way into hospitals, according to a stu...iseases . , The new threat is easily picked up ...es and has increased the overall burden of MRSA wi...
(Date:11/23/2009)...ngton, CT Current research suggests that a common... The related report by Nichols et al, "Unique Lip...Class of TLR2 Ligands Capable of Enhancing Autoimm... American Journal of Pathology . , Multiple scle...cks the brain and spinal cord, affects nearly 1 in...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Cambrex Continuous Flow Microwave Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award 5599 1Cambrex Continuous Flow Microwave Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award 5599 2Babies Injured in Car Seats Used Outside of Cars 59817 1Babies Injured in Car Seats Used Outside of Cars 59817 2Babies Injured in Car Seats Used Outside of Cars 59817 3School Meals Need to Get Healthier 3A Report 59815 1School Meals Need to Get Healthier 3A Report 59815 2School Meals Need to Get Healthier 3A Report 59815 3School Meals Need to Get Healthier 3A Report 59815 4
...nced the winners of its student travel award to at...and the International Biophysics Congress in Long ...nts of this competitive award are selected based o...ho will present a paper at the conference. Each a...zed at a reception on Saturday, February 2, 2008. ...
...diopathic pulmonary fibrosis is a disease with unk...cted, it is already in an advanced stage. Patients...ulmonary gas exchange, and have a very reduced qua...tment, they rarely survive 5 years after being dia...ut of 100,000 men and 7 out of 100,000 women, norm...
...unds could make sutures a relic of medical history...laced on a surgical wound and exposed to an infrar... it and the tissue, thus perfectly sealing the wou... is extracted from crab shells and has Food and Dr...t results indicate that it has strongest potential...
Other Biology News:Biophysical Society announces winners of 2008 Student Travel Awards 2Biophysical Society announces winners of 2008 Student Travel Awards 3Biophysical Society announces winners of 2008 Student Travel Awards 4Biophysical Society announces winners of 2008 Student Travel Awards 5Translational research patented first experimental treatment against idiopathic pulmonary fibrosis 2Surgery without stitches 2
Rat Anti-Mouse Endoglin Monoclonal Antibody, Fluorescein Conjugated, Clone 209701 from R&D Systems
Goat Anti-Rat CNTF R alpha Polyclonal Antibody, Unconjugated from R&D Systems
Rat Anti-Human MFRP Monoclonal Antibody, Unconjugated, Clone 291218 from R&D Systems
Goat Anti-Human RELT / TNFRSF19L Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: